Marshall Wace’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$47.9M Buy
1,092,516
+315,876
+41% +$14.4M 0.05% 374
2025
Q4
$34.4M Buy
776,640
+365,736
+89% +$15.8M 0.03% 454
2025
Q3
$17.3M Sell
410,904
-45,628
-10% -$1.84M 0.02% 715
2025
Q2
$16.7M Sell
456,532
-119,119
-21% -$4.42M 0.02% 653
2025
Q1
$21.9M Buy
575,651
+437,911
+318% +$16.3M 0.03% 492
2024
Q4
$5.21M Sell
137,740
-206,722
-60% -$8.26M 0.01% 1042
2024
Q3
$14M Sell
344,462
-267,560
-44% -$10.1M 0.02% 635
2024
Q2
$21M Buy
+612,022
New +$19.3M 0.03% 482
2023
Q4
Sell
-1,360,569
Closed -$45.1M 2484
2023
Q3
$45.1M Sell
1,360,569
-1,371,410
-50% -$43.8M 0.09% 228
2023
Q2
$83.8M Buy
2,731,979
+1,641,488
+151% +$47.4M 0.16% 136
2023
Q1
$29.9M Buy
1,090,491
+268,071
+33% +$7.46M 0.06% 324
2022
Q4
$23M Buy
822,420
+88,507
+12% +$2.67M 0.05% 405
2022
Q3
$21.6M Buy
733,913
+109,736
+18% +$3.44M 0.05% 435
2022
Q2
$17.6M Buy
624,177
+606,360
+3,403% +$17.3M 0.04% 531
2022
Q1
$555K Buy
+17,817
New +$525K ﹤0.01% 2727
2021
Q3
Sell
-262,020
Closed -$9.51M 3303
2021
Q2
$9.51M Sell
262,020
-183,215
-41% -$6.8M 0.04% 512
2021
Q1
$16.3M Buy
445,235
+415,073
+1,376% +$15.3M 0.07% 269
2020
Q4
$1.1M Buy
+30,162
New +$1.02M 0.01% 1174
2020
Q3
Sell
-75,308
Closed -$2.24M 1821
2020
Q2
$2.24M Buy
+75,308
New +$2.23M 0.02% 749
2020
Q1
Sell
-20,625
Closed -$873K 1942
2019
Q4
$873K Buy
20,625
+14,677
+247% +$621K 0.01% 1019
2019
Q3
$249K Buy
+5,948
New +$232K ﹤0.01% 1243
2019
Q2
Sell
-81,129
Closed -$3.1M 1697
2019
Q1
$3.1M Buy
+81,129
New +$3.01M 0.03% 618

Other funds holding OHI

Marshall Wace's OHI Position: Q1 2026 in Review

Marshall Wace increased its Omega Healthcare (OHI) stake by 41% in Q1 2026, buying an estimated $14.4M and bringing the position to 1,092,516 shares worth $47.9M. The position accounts for 0.05% of the portfolio, ranked #374.

Marshall Wace first reported a position in OHI in Q1 2019 and has held it in 22 quarters since. The position peaked at $83.8M in Q2 2023. 740 funds tracked by Wall St. Rank hold OHI as of Q1 2026.

  • Marshall Wace held 1,092,516 shares of Omega Healthcare worth $47.9M as of Q1 2026.
  • Marshall Wace bought 315,876 Omega Healthcare shares in Q1 2026, an estimated $14.4M.
  • Omega Healthcare made up 0.05% of Marshall Wace's portfolio in Q1 2026, its #374 holding.
  • Marshall Wace first reported a position in Omega Healthcare in Q1 2019 and has held it in 22 quarters since.
  • Marshall Wace's Omega Healthcare position peaked at $83.8M in Q2 2023.
  • 740 funds tracked by Wall St. Rank held Omega Healthcare as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.